Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
05/08/2013 | CN103083690A Capsule for gastrointestinal color ultrasound contrast |
05/08/2013 | CN103083689A Cross-blood-brain-barrier targeting multimodal nano-medicine used in brain tumor diagnosis |
05/08/2013 | CN103083688A Ferrate magnetic nanocomposite with core-shell structure, preparation method and application thereof |
05/08/2013 | CN103083687A Application of silver and platinum nano-cluster in tumor targeted imaging |
05/08/2013 | CN103083133A Fundus disease laser photo-thermal treatment system based on gold nanorods |
05/08/2013 | CN102492686B Kctd10 gene knock-out mouse model, construction method and application thereof |
05/08/2013 | CN102228702B Method for preparing dendrimer mediated gold-silver alloy nanoparticles |
05/08/2013 | CN102174170B Polyurethane material and application thereof as X-ray developing material and magnetic material |
05/08/2013 | CN101616692B Polychromatic, diversely-sized particles for angiography |
05/07/2013 | US8435496 Nanoparticle clusters and methods for forming same |
05/07/2013 | US8435495 Characterization of granulocytic Ehrlichia and methods of use |
05/07/2013 | US8435494 Mesothelin antibody protein fusions and methods of use |
05/07/2013 | CA2564197C Activatable particles, preparations and uses |
05/07/2013 | CA2383982C Transgenic animal expressing a multiple mutated form of presenilin 1 |
05/02/2013 | WO2013062202A1 Mri contrast agent coated with amphoteric ion |
05/02/2013 | WO2013061818A1 Novel peptide complex and hybrid complex thereof, and use of said hybrid complex |
05/02/2013 | WO2013060919A1 Controlled synthesis of polyglutamates with low polydispersity and versatile architectures |
05/02/2013 | WO2013036869A3 Compositions, methods, and systems for the synthesis and use of imaging agents |
05/02/2013 | WO2013036543A3 Molecular imaging of cancer cells in vivo |
05/02/2013 | WO2013020040A3 Radiated cancer cells as a vehicle for cancer nanotherapy |
05/02/2013 | US20130108554 Contrast agents |
05/02/2013 | US20130108553 Metal Mixes For Use In Epicutaneous Patch Test |
05/02/2013 | US20130108552 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same |
05/02/2013 | US20130108550 Bioabsorbable Co-Filler for Cerebrovascular Aneurysms |
05/02/2013 | US20130108546 Humanized Antibodies That Recognize Alpha-Synuclein |
05/02/2013 | CA2853705A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
05/01/2013 | EP2585611A2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
05/01/2013 | EP2585116A2 Modeling of pharmaceutical propagation and parameter generation for injection protocols |
05/01/2013 | CN103079642A Nanoparticle-guided radiotherapy |
05/01/2013 | CN103079599A Targeted gas-filled microvesicles |
05/01/2013 | CN103079598A Single isomeric conjugates of rhodamine dyes |
05/01/2013 | CN103079592A Method for treating and diagnosing cancer by using cell-derived microvesicles |
05/01/2013 | CN101321750B Multimeric magnetic resonance contrast agents |
05/01/2013 | CN101019028B Compounds and methods for combined optical-ultrasound imaging |
04/30/2013 | US8431723 Radicals and their use as paramagnetic agents in a DNP process |
04/30/2013 | US8431118 Anti-herpes simplex virus antibodies and methods of use thereof |
04/30/2013 | US8431110 Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators |
04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
04/30/2013 | CA2567064C Optical sensor for in vivo detection of analyte |
04/25/2013 | WO2013059437A1 Inhibitors of arginase and their therapeutic applications |
04/25/2013 | WO2013058774A1 Compositions comprising ascorbic acid and an imaging agent and related methods |
04/25/2013 | WO2013058482A2 Multi-functional nucleic acid-based anti-cancer drug capable of targeting and therapy, method for preparing same and anti-cancer composition comprising same |
04/25/2013 | WO2013057933A1 Contrast agent, contrast agent kit, and method for administering contrast agent |
04/25/2013 | WO2012174285A3 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease |
04/25/2013 | WO2012173933A3 Activatable nanoprobes for intracellular drug delivery |
04/25/2013 | WO2012037928A3 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium |
04/25/2013 | US20130102898 Liposome including elastin-like polypeptides and use thereof |
04/25/2013 | US20130102897 Modeling of pharmaceutical propagation |
04/25/2013 | US20130101522 Ultrasound Contrast Agents And Process For The Preparation Thereof |
04/25/2013 | US20130101520 Ultrasound contrast agents and methods of making and using them |
04/25/2013 | US20130101519 Diagnostic Method for Atherosclerosis |
04/25/2013 | US20130101518 Method and apparatus for kidney function analysis |
04/25/2013 | US20130101515 Method of selecting antioxidants for use in topically applied compositions |
04/25/2013 | US20130101513 Method of using near infrared fluorescent dyes for imaging and targeting cancers |
04/25/2013 | US20130101512 Crosslinked polynucleotide structure |
04/25/2013 | US20130101511 In vivo imaging of enzymatic activity |
04/25/2013 | US20130101506 Compositions comprising nucleic acid aptamers |
04/25/2013 | CA2852395A1 Compositions comprising ascorbic acid and an imaging agent and related methods |
04/24/2013 | EP2583981A2 Antibodies and related molecules that bind to PSCA proteins |
04/24/2013 | EP2582400A2 Tuned multifunctional magnetic nanoparticles for biomedicine |
04/24/2013 | CN103069274A Method for quantitative measurement of gastric acidity using 13c carbonate salt |
04/24/2013 | CN103068830A Inhibitors of arginase and their therapeutic applications |
04/24/2013 | CN103055329A Manufacturing method of targeted magnetic nanometer probe for early diagnosis of atherosclerosis vulnerable plaques |
04/24/2013 | CN103055328A Degradable dendritic macromolecule magnetic resonance contrast agent and preparation method thereof |
04/24/2013 | CN103055327A Bifunctional contrast agent for fluorescence imaging and magnetic resonance imaging |
04/24/2013 | CN103055314A 雌激素的应用 Application of estrogen |
04/24/2013 | CN103055312A Application of ferroferric oxide as photo-thermal sensitive material |
04/24/2013 | CN102125699B Fe3O4/TiO2 composite nano-particles as well as preparation method and application thereof in magnetic resonance imaging contrast medium |
04/23/2013 | US8425880 Metal-containing materials for treatment of bacterial conditions |
04/23/2013 | US8425879 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy |
04/23/2013 | US8425878 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |
04/23/2013 | US8425877 Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody |
04/23/2013 | CA2567429C Restless legs syndrome/periodic appendicular dyskinesia model animal |
04/23/2013 | CA2562170C 5-aminolevulinic acid salt, process for producing the same and use thereof |
04/23/2013 | CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
04/18/2013 | WO2013056132A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
04/18/2013 | WO2013056092A1 Multi-component nanochains |
04/18/2013 | WO2013055791A1 Polymeric nanoparticles for ultrasound imaging and therapy |
04/18/2013 | WO2013054126A2 Nanocolloids for local temperature monitoring |
04/18/2013 | WO2013053927A1 Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester |
04/18/2013 | WO2013053839A1 Process for the preparation of hyperpolarized derivatives for use in mri analysis |
04/18/2013 | WO2013053042A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents. |
04/18/2013 | US20130096420 Process For Preparing Hyperpolarized Substrates And Method For MRI |
04/18/2013 | US20130095041 Skin Profiling and Its Use in Testing Cosmetics |
04/18/2013 | US20130095040 Dye compositions and dye syntheses |
04/18/2013 | US20130095039 Nucleic acid-mediated shape control of nanoparticles |
04/18/2013 | US20130095038 Particles, and photoacoustic imaging contrast agent and sln contrast agent including the particles |
04/18/2013 | US20130095036 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
04/18/2013 | CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof |
04/18/2013 | CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
04/18/2013 | CA2851614A1 Compositions useful in treating nephropathy and methods for preparation of same |
04/18/2013 | CA2849538A1 Porphyrin microbubbles |
04/17/2013 | CN103045606A K14-VEGF transgenic mouse model, and construction method and application of model |
04/17/2013 | CN103043724A Oxidized graphene/MnFe2O4 nanometer hybrid material and preparation method thereof |
04/17/2013 | CN103041410A Contrast powder for gastrointestinal ultrasonic diagnosis |
04/17/2013 | CN103041409A Preparation method of pH and thermal dual-sensitive lipidosome loaded with magnetic carbon quantum dots on internal water phase |
04/17/2013 | CN103041408A Core-shell type nano-contrast agent, preparation method and application thereof |
04/17/2013 | CN103041407A Core-shell type nano-contrast agent, preparation method and application thereof |
04/17/2013 | CN103041406A Method for preparing diagnosis and treatment-cooperated nano particles release system by template method |
04/17/2013 | CN103041405A Diagnosis-treatment integrative medicine carrying polymer and preparation method thereof |